Replies to post #363230 on Amarin Corp Plc (AMRN)

[xblkbk]

Thanks FFS

Just wish you were saying interesting in terms of ring of fire volcanoes and not ring of fire depths of hell. : ).

Eight large caps (JNJ, PFE, NVS, Roche, MRK, BMY, GSK, ABBV) have potential M&A capacity of >$100bn. Many face a looming growth crisis in 2025-2030

They must be salivating at the valuations a lot of small biotechs are hitting.

2022 could be interesting for small cap bio in general (and hopefully AMRN too).

All the Best,
xblkbk

[Judge Smails 40]

Good chart, but def bad news. XBI has been brutal since the ugly topping monthly candle a year ago, nowhere near bottom IMO